Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2621]

UCLA researchers discover aggressive prostate and lung cancers are driven by common mechanisms

UCLA researchers discover aggressive prostate and lung cancers are driven by common mechanisms

Pathology test uses AI to predict prostate cancer progression following surgery

Pathology test uses AI to predict prostate cancer progression following surgery

Adherence to annual lung cancer screening needs improvement

Adherence to annual lung cancer screening needs improvement

Researchers use new technique to identify a novel drug combination for NSCLC

Researchers use new technique to identify a novel drug combination for NSCLC

FDA approves dacomitinib for the first-line treatment of patients with EGFRm metastatic NSCLC

FDA approves dacomitinib for the first-line treatment of patients with EGFRm metastatic NSCLC

Phase III study shows nintedanib combo therapies did not improve PFS or OS in malignant pleural mesothelioma

Phase III study shows nintedanib combo therapies did not improve PFS or OS in malignant pleural mesothelioma

Hybrid operating room streamlines diagnosis, treatment of lung cancer

Hybrid operating room streamlines diagnosis, treatment of lung cancer

Atezolizumab improves outcomes for SCLC when added to SOC

Atezolizumab improves outcomes for SCLC when added to SOC

NELSON study shows CT screening for nodule volume management reduces lung cancer mortality by 26% in men

NELSON study shows CT screening for nodule volume management reduces lung cancer mortality by 26% in men

Poziotinib maintains high response rate against harmful lung cancer mutation

Poziotinib maintains high response rate against harmful lung cancer mutation

More from ecancer